Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The San Francisco Heart Institute (SFHI) is a specialized cardiovascular center based at Seton Medical Center in Daly City, California. It is historically significant for being the site of the first coronary angioplasty performed in the United States in 1978 by Dr. Richard Myler and Dr. Simon Stertzer. Today, the institute continues to provide advanced cardiac care, including interventional cardiology, electrophysiology, and cardiothoracic surgery. It also serves as a site for clinical trials evaluating new cardiovascular technologies and therapeutic approaches. The institute is currently part of the AHMC Healthcare system following its acquisition of Seton Medical Center. SFHI remains a key destination for complex heart disease management in the San Francisco Bay Area.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on San Francisco Heart Institute.